Parkin as a tumor suppressor gene for hepatocellular carcinoma (Q42811415)

7 November 2017

Parkin as a tumor suppressor gene for hepatocellular carcinoma (English)

1 reference

7 November 2017

M Fujiwara

1

1 reference

7 November 2017

H Marusawa

2

1 reference

7 November 2017

H-Q Wang

3

1 reference

7 November 2017

A Iwai

4

1 reference

7 November 2017

K Ikeuchi

5

1 reference

7 November 2017

Y Imai

6

1 reference

7 November 2017

A Kataoka

7

1 reference

7 November 2017

N Nukina

8

1 reference

7 November 2017

R Takahashi

9

1 reference

7 November 2017

T Chiba

10

1 reference

7 November 2017

language of work or name

English

0 references

publication date

23 June 2008

1 reference

7 November 2017

1 reference

7 November 2017

27

1 reference

7 November 2017

46

1 reference

7 November 2017

6002-6011

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2008.199

7 November 2017

0 references

cites work

Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Molecular Pathways of Neurodegeneration in Parkinson's Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Cloning and analysis of the mouse follistatin promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Alterations in the common fragile site gene Parkin in ovarian and other cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Hepatocellular carcinoma pathogenesis: from genes to environment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Genetics of Parkinson disease: paradigm shifts and future prospects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Genetic mechanisms of hepatocarcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Expression profiling of CC531 colon carcinoma cells reveals similar regulation of beta-catenin target genes by both butyrate and aspirin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Deregulation of the activin/follistatin system in hepatocarcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Rules for making human tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Antagonists of activin signaling: mechanisms and potential biological applications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Induction of apoptosis in the murine liver with recombinant human activin A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Parkin suppresses the expression of monoamine oxidases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

How does parkin ligate ubiquitin to Parkinson's disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Pael receptor induces death of dopaminergic neurons in the substantia nigra via endoplasmic reticulum stress and dopamine toxicity, which is enhanced under condition of parkin inactivation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

The role of activin and transforming growth factor-beta in the regulation of organ mass in the rat liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

M6P/IGF2R is mutated in squamous cell carcinoma of the lung

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Genetics of hepatocellular tumors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Genetic instabilities in human cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

HBXIP functions as a cofactor of survivin in apoptosis suppression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Expression of APOBEC2 is transcriptionally regulated by NF-kappaB in human hepatocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

A novel transactivation domain in parkin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Parc: a cytoplasmic anchor for p53.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Mitochondrial dysfunction and oxidative damage in parkin-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Parkin-deficient mice are not a robust model of parkinsonism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

The activin axis in liver biology and disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

At least five regions of imbalance on 6q in breast tumors, combining losses and gains

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Follistatin overexpression in rodent liver tumors: a possible mechanism to overcome activin growth control

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Chapter 4 Preparation of Isolated Rat Liver Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Adenovirus-mediated overexpression of follistatin enlarges intact liver of adult rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Application of tyramide signal amplification system to immunohistochemistry: a potent method to localize antigens that are not detectable by ordinary method

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Loss of locus coeruleus neurons and reduced startle in parkin null mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

Parkin gene alterations in hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

To die or grow: Parkinson's disease and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

inferred from DOI database lookup

7 January 2021

based on heuristic

Parkin and endoplasmic reticulum stress

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.199

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/ONC.2008.199

1 reference

Dimensions Publication ID

7 November 2017

0 references

1 reference